Bruker's Mass-Spec Sales Grow in Double Digits in Q2; Total Revenue Declines 18.9 Percent
July 30, 2009
Bruker's Mass-Spec Sales Grow in Double Digits in Q2; Total Revenue Declines 18.9 Percent
According to Frank Laukien, president and CEO of the company, "for our high performance mass spectrometry solutions, we continue to see healthy revenue and order growth year over year."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Proteomics Technologies Making Their Way into Pathogen Detection
August 19, 2011 / ProteoMonitor - Bruker Posts 33 Percent Rise in Q2 Revenues, Notes Strong Interest in New Mass Spec Systems
August 5, 2011 / ProteoMonitor - EU Funds $11.5M Initiative to Offer Proteomics Services and Drive Tool Development
July 8, 2011 / ProteoMonitor - Thermo Fisher's New Orbitrap Elite Poses Challenge to FT-ICR's Dominance in Top-Down Proteomics
July 1, 2011 / ProteoMonitor - BGI Aims to Expand Proteomics Services, Purchase 50-Plus New Mass Spectrometers
June 17, 2011 / ProteoMonitor